Caliper Life Sciences’ Third Quarter 2006 Financial Results Conference Call Notice

HOPKINTON, Mass., Oct. 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. will conduct a conference call discussing the company's third quarter 2006 financial results at 9:00 a.m. EST on Thursday, November 9, 2006. Kevin Hrusovsky, President and Chief Executive Officer and Tom Higgins, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's third quarter 2006 financial results will be issued Thursday, November 9, at approximately 7:00 a.m. EST.

Participants, please call 866-510-0707 five to ten minutes prior to the call and use the participant passcode of 26876346. International callers can access the call by dialing 617-597-5376 and entering the same passcode.

A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the fourth quarter of 2006.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from November 9 through November 16, dial 888-286-8010 and use the participant passcode of 29811510. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its recent acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper's products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. More information about Caliper can be found at www.caliperLS.com .

NOTE: Caliper is a trademark of Caliper Life Sciences, Inc.

Caliper Life Sciences, Inc.

CONTACT: Michele Boudreau of Caliper Life Sciences, +1-650-279-2088

MORE ON THIS TOPIC